The global Biosimilars Market, valued at US$32.75 billion in 2024 stood at US$35.04 billion in 2025 and is projected to advance at a resilient ...

Sun Pharma shares plunged over 2%, extending losses for the second consecutive session. Notably, it is currently the top ...

The company set the floor price at Rs 340.20 per share, according to an exchange filing on Monday. It may offer a discount of not more than 5% on the floor price.

Karnataka: Syngene International has announced that the Company has received Establishment Inspection Report (EIR) from US ...

India's AI-driven biomanufacturing potential, challenges, and the need for balanced regulations and accountability in a ...

The facility can continue selling approved drugs and will also receive approvals for new filings. Shares of Syngene ...

LONDON, GREATER LONDON, UNITED KINGDOM, June 13, 2025 /EINPresswire.com/ -- There has been a significant expansion in the cyclosporine drugs market size in recent years. The detailed analysis suggests ...

Key companies, such as CSL Behring, Equillium, Biocon, and medac, are advancing their assets through late-stage graft versus host disease clinical trials, driving innovation in the graft versus ...

Key companies, such as CSL Behring, Equillium, Biocon, and medac, are advancing their assets through late-stage graft versus ...

The UnitedHealth Group division is taking Johnson & Johnson's Stelara — one of the most popular, best-known and most expensive "biologic" anti-inflammatory drugs — off the standard formulary for many ...

Pfizer Inc. plans to spend billions of dollars to join the race for a new type of cancer treatment. Similar to its competitors, Pfizer also plans to partner with a Chinese company. The company PFE ...

Eli Lilly & Co. sees 60% sales increase for weight-loss drug in India, tapping into growing demand for anti-obesity solutions ...